Todos Medical Ltd is a clinical-stage biotechnology company focused on the development and commercialization of novel diagnostic tools and therapeutic treatments for cancer, infectious diseases and inflammatory conditions. Established through a series of strategic acquisitions and collaborations, the company leverages proprietary immunoassay technology to measure the functional response of white blood cells and to identify disease activity in real time. Todos Medical’s core mission is to enable earlier detection of serious illnesses and to support personalized treatment decisions that can improve patient outcomes.
In its diagnostics segment, Todos Medical offers a suite of blood-based tests designed to assess immune system function and to detect disease markers associated with viral infections, food sensitivities and malignancies. The company’s flagship Leukocyte Dynamics Test evaluates the activation of white blood cells in response to specific stimulants, providing a snapshot of a patient’s immune competence. During the COVID-19 pandemic, Todos Medical expanded its portfolio to include rapid antigen and antibody screening assays, which have been deployed in clinical and point-of-care settings.
On the therapeutics side, Todos Medical is advancing a pipeline of drug candidates targeting oncology and inflammatory pathways. Among these is an experimental regimen for pancreatic cancer that combines immune modulation with targeted chemotherapy, as well as novel anti-inflammatory compounds aimed at reducing cytokine-driven tissue damage. The company collaborates with academic institutions and contract research organizations to conduct preclinical studies and to initiate early-stage clinical trials.
Headquartered in New York with research facilities in the United States and partnerships in Europe and Asia, Todos Medical serves hospitals, diagnostic laboratories and specialty clinics worldwide. Its management team brings decades of experience in biotechnology development, regulatory affairs and commercial scale-up. Under this leadership, Todos Medical continues to broaden its product pipeline and to pursue regulatory approvals, positioning itself as an emerging player in the global molecular diagnostics and specialty therapeutics markets.
AI Generated. May Contain Errors.
Free TOMDF Stock Alerts